APO-CEFEPIME
APOTEX INC
Quick answers
Is there a shortage of APO-CEFEPIME in Canada?
No. There is no current shortage of APO-CEFEPIME 2G reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MAXIPIME FOR INJECTION-PWS IV 2GM
BRISTOL-MYERS SQUIBB CANADA
Other Products
MAXIPIME FOR INJECTION -PWS IV IM 1G
BRISTOL-MYERS SQUIBB CANADA
CEFEPIME FOR INJECTION USP
HIKMA CANADA LIMITED
CEFEPIME FOR INJECTION, USP
QILU PHARMACEUTICAL CO., LTD.
DIN
02467518
Strength
2G
Dosage Form
Powder For Solution
Route
Intravenous
Active Ingredient
CEFEPIME (CEFEPIME HYDROCHLORIDE)
See all CEFEPIME (CEFEPIME HYDROCHLORIDE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178